Inventor
SHIOW-LIN PAN
Inventor
TW
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds20%
C07CAcyclic or carbocyclic compounds7%
C07KPeptides7%
PatentTitleYear
11,919,858Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases202411,578,121Anti-EGF like domain multiple 6 (EGFL6) antibodies202311,479,528Heat shock protein 90 inhibitors202211,427,544Histone deacetylase 6 inhibitors and use thereof202211,278,523Indoline derivatives for treatment and/or prevention of fibrosis diseases2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to UNIV TAIPEI MEDICAL (4)· patent assignee history
2022Patents assigned to UNIV NAT TAIWAN (1)· patent assignee history
2022–2024Based in TW· patent location history
2023Patents assigned to CHANGHUA CHRISTIAN MEDICAL FOUND CHANGHUA CHRISTIAN HOSPITAL (1)· patent assignee history
2023Patents assigned to NATIONAL RES INSTITUTE OF CHINESE MEDICINE MINISTRY OF HEALTH AND WELFARE (1)· patent assignee history
2024Patents assigned to CALGENT BIOTECHNOLOGY CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV TAIPEI MEDICAL | 4 | 2022–2023 |
| CALGENT BIOTECHNOLOGY CO LTD | 1 | 2024 |
| CHANGHUA CHRISTIAN MEDICAL FOUND CHANGHUA CHRISTIAN HOSPITAL | 1 | 2023 |
| NATIONAL RES INSTITUTE OF CHINESE MEDICINE MINISTRY OF HEALTH AND WELFARE | 1 | 2023 |
| UNIV NAT TAIWAN | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| TW | 5 | 2022–2024 |